Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Radioimmunoscintigraphy of colon cancer with iodine-131-labeled B72. 3 monoclonal antibody

Journal Article · · J. Nucl. Med.; (United States)
OSTI ID:6924236

The monoclonal antibody B72.3 is a murine IgG1 that is reactive with a wide range of carcinomas while demonstrating little or no reactivity to normal adult tissues. We have shown quantitative analyses demonstrating selective targeting of (/sup 131/I)B72.3 IgG to metastatic colorectal cancer. We have also shown that (a) B72.3 localization in metastases correlated with the percentage of tumor cells in the biopsy specimen; (b) B72.3 could localize in carcinomas of various degrees of differentiation with best localization in well-differentiated tumors and (c) (/sup 131/I)B72.3 could penetrate tumor masses, as determined by autoradiographic studies. We report here the various parameters effecting radioimmunoscintigraphy with (/sup 131/I)B72.3 IgG. Sixteen of 35 patients with colorectal carcinoma had positive scans (without blood-pool subtraction). High circulating TAG-72 antigen levels correlated with positive scans. No dose dependent differences were seen in biodistribution or tumor imaging. The plasma clearance and urinary excretion of (/sup 131/I)B72.3 and (/sup 125/I)BL-3 (nonspecific control) were not significantly different. No toxicity was noted. Approximately one-half of patients developed human anti-mouse immune response.

Research Organization:
National Cancer Institute, Bethesda, MD (USA)
OSTI ID:
6924236
Journal Information:
J. Nucl. Med.; (United States), Journal Name: J. Nucl. Med.; (United States) Vol. 29:6; ISSN JNMEA
Country of Publication:
United States
Language:
English